BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1032373)

  • 1. Plasma immunoreactive insulin (IRI) and glucose tolerance in bilharzial hepatic fibrosis.
    el-Badry A; el-Ayadi A; Hassaballah AM; Barsoum RS; Shaheen MH; Abdel-Rahman MY; el-Bagoury I; Ibrahim Z
    J Egypt Med Assoc; 1976; 59(1-2):5-22. PubMed ID: 1032373
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma insulin; insulin resistance and glucose intolerance in children with bilharzial hepatic fibrosis.
    Zaki K; Kantoosh M; Hamam MA; Shoheib S; Mikhail N; Nour H; Zaki F
    Hepatogastroenterology; 1980 Dec; 27(6):417-22. PubMed ID: 7009363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ceruloplasmin in bilharzial hepatic fibrosis.
    Fayez M; Aziz S; el-Shiek A; el-Gengehy MT; Ziada A
    J Egypt Med Assoc; 1969; 52(10):737-47. PubMed ID: 5383229
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic activity in bilharzial hepatic fibrosis.
    el-Attar O; Shaheen H; el-Saadani AM; Madwar K; Erfan A; Kinawi M; el-Saifi
    J Egypt Med Assoc; 1972; 55(7):512-9. PubMed ID: 4657616
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-fetoprotein in adult normals, bilharzial hepatic fibrosis and viral hepatitis in Egypt.
    El-Haieg MO; Ibrahim II; Zanaty MF
    J Egypt Med Assoc; 1977; 60(9-12):699-706. PubMed ID: 89127
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipids in bilharzial hepatic fibrosis.
    Gabr Y; Fouda H; Mahfouz M; Amin ES
    Acta Biol Med Ger; 1973; 31(3):407-13. PubMed ID: 4775348
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma immuno-reactive insulin (IRI) and peripherel glucose utilization in bilharzial patients with impaired renal functions.
    El-Badry A; Hassaballah AM; El-Ayadi A; Barsoum RS; Shaheen MH; El-Ghoneimy EH; Abdel-Rahman Y; El-Bagoury I
    J Egypt Med Assoc; 1975; 58(7-8):361-9. PubMed ID: 1236509
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum fatty acid changes in typhoid fever and bilharzial hepatic fibrosis.
    el-Hawy AM; el-Nasr MS; Abdel-Rahman MM; Mahmoud MS; Bistawy MB
    J Egypt Soc Parasitol; 1988 Jun; 18(1):185-91. PubMed ID: 3373045
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive insulin in schistosomal hepatic fibrosis.
    Nofal M; el-Sawy M
    J Trop Med Hyg; 1973 Jan; 76(1):16-8. PubMed ID: 4684162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood glucose level in hepato-intestinal schistosomiasis].
    Pricoli TI; Guimarães RX; Carneiro Neto JT; de Oliveira Filho JB
    Arq Gastroenterol; 1981; 18(3):118-21. PubMed ID: 7340751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional and immunologic evaluation of prothrombin in the hepatosplenic form of schistosomiasis and hepatic cirrhosis].
    Manoukian N; Borges DR
    Rev Paul Med; 1983; 101(5):182-5. PubMed ID: 6672979
    [No Abstract]   [Full Text] [Related]  

  • 12. Some metabolic studies and its correlation with clinical condition in bilharzial hepatic fibrosis.
    el-Assiouty IM; Rashed SM; Mostafa MA; Mahdy Z; Kabil S
    J Egypt Soc Parasitol; 1986 Dec; 16(2):593-600. PubMed ID: 3537158
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatty acid composition of serum lipids in bilharzial hepatic fibrosis and chronic active hepatitis.
    Gabr Y; Mahfouz M; Mohammed YS
    Acta Biol Med Ger; 1975; 34(1):45-51. PubMed ID: 1179920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin and glycodiazine on the level of plasma free fatty acids in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK
    J Trop Med Hyg; 1972 Jun; 75(6):115-8. PubMed ID: 5044326
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum beta-2-microglobulin in intestinal and hepatosplenic bilharziasis.
    Nasser HE; Amer MS; Taha MA; Shawkat A; Abo-Elmaged L; El Missiry AG; Khalil I; Schoukry NA; Abdel Mohsen A; Soliman H
    J Egypt Soc Parasitol; 1983 Dec; 13(2):423-7. PubMed ID: 6363570
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin levels and glucose intolerance in patients with cirrhosis and non cirrhotic portal fibrosis.
    Vij JC; Gaur SK; Sharma SK; Yadav HS; Kumar N; Anand BS
    J Assoc Physicians India; 1987 Jul; 35(7):479-82. PubMed ID: 3323185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma levels of conjugated bile acids in chronic schistosomal liver diseases].
    Parise ER; Barbosa LB; Novo NF; Guimarães RX
    Rev Paul Med; 1984; 102(3):113-7. PubMed ID: 6474037
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in carbohydrate metabolism in hepatic cirrhosis. IV. Resistance to the effect of insulin].
    Santolaria Fernández F; González Garciá C; González Reimers E; Burgos Ojeda A; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Apr; 63(4):349-56. PubMed ID: 6348895
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on portal hypertension and its relation to serum histamine level in patients with bilharzial hepatic fibrosis.
    El-Hawey AM; Gaber A; Saber MA; Abou-Taleb S
    J Egypt Med Assoc; 1978; 61(3-4):299-311. PubMed ID: 556093
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.